Anzeige
Meldung des Tages: Der Vorteil des Meeresbodens: Wie Tiefsee-Knollen den landbasierten Bergbau übertreffen könnten

Nuvation Bio News

Aktie
WKN:  A2QPAG ISIN:  US67080N1019 US-Symbol:  NUVB Branche:  Biotechnologie Land:  USA
5,08 $
+0,27 $
+5,61%
4,3183 € 17.04.26
Depot/Watchlist
Marktkapitalisierung *
2,74 Mrd. €
Streubesitz
15,16%
KGV
-19,87
Index-Zuordnung
-

Nuvation Bio News

02.04.26 - PR Newswire
Kuehn Law Encourages Investors of Nuvation Bio Inc. to Contact Law Firm
Kuehn Law Encourages Investors of Nuvation Bio Inc. to Contact Law Firm PR Newswire
01.04.26 - PR Newswire
Nuvation Bio Announces Acquisition of Japan Rights to Safusidenib from Daiichi Sankyo
Nuvation Bio Announces Acquisition of Japan Rights to Safusidenib from Daiichi Sankyo PR Newswire
26.03.26 - PR Newswire
Eisai and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated by the European Medicines Agency
Eisai and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated by the ...
26.03.26 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB PR Newswire
19.03.26 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB PR Newswire
17.03.26 - PR Newswire
Nuvation Bio to Present Pivotal IBTROZI® (Taletrectinib) Data in TKI-Naïve and TKI-Pretreated Patients with Advanced ROS1-Positive Non-Small Cell Lung Cancer at AACR 2026
Nuvation Bio to Present Pivotal IBTROZI® (Taletrectinib) Data in TKI-Naïve and TKI-​Pretreated Patients with Advanced ROS1-Positive Non-Small Cell Lung Cancer at AACR 2026 PR ...
12.03.26 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVB PR Newswire
06.03.26 - PR Newswire
Kuehn Law Encourages Investors of Nuvation Bio Inc. to Contact Law Firm
Kuehn Law Encourages Investors of Nuvation Bio Inc. to Contact Law Firm PR Newswire
02.03.26 - PR Newswire
Nuvation Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Nuvation Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update PR Newswire
25.02.26 - PR Newswire
Nuvation Bio to Participate in Upcoming Investor Conferences
Nuvation Bio to Participate in Upcoming Investor Conferences PR Newswire
17.02.26 - PR Newswire
Nuvation Bio to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 2, 2026
Nuvation Bio to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 2, 2026 PR Newswire
17.02.26 - PR Newswire
New Treatment Modalities Are Reaching Cancers That Resisted Everything Else
New Treatment Modalities Are Reaching Cancers That Resisted Everything Else PR Newswire
17.02.26 - PR Newswire
New Treatment Modalities Are Reaching Cancers That Resisted Everything Else
New Treatment Modalities Are Reaching Cancers That Resisted Everything Else PR Newswire
06.12.25 - PR Newswire
Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List
Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List PR Newswire
08.10.25 - PR Newswire
NYSE Content Advisory: Pre-Market Update + The AW Playmaker Awards Take the Stage at 11 Wall Street
NYSE Content Advisory: Pre-​Market Update + The AW Playmaker Awards Take the Stage at 11 Wall Street PR Newswire
08.10.25 - PR Newswire
NYSE Content Advisory: Pre-Market Update + The AW Playmaker Awards Take the Stage at 11 Wall Street
NYSE Content Advisory: Pre-​Market Update + The AW Playmaker Awards Take the Stage at 11 Wall Street PR Newswire
10.07.25 - PR Newswire
Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up
Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up PR Newswire
10.07.25 - PR Newswire
Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up
Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up PR Newswire

Newssuche

Videos

newspaper
16.04.26 +2,80%
Technical Trading: Treffsichere Signale für Gold
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »